Multiple Sclerosis
The AJMC® Multiple Sclerosis compendium is a comprehensive resource for clinical news and expert insights for the disabling disease that impacts the brain and spinal cord.
Examining the Role of a Novel Class of Medications for the Management of Multiple Sclerosis
This video series provides an in-depth look at multiple sclerosis, covering its impact, pathophysiology, treatment strategies, unmet needs, patient satisfaction, and future research. Gain key insights into managing and understanding this condition.
.png?fit=crop&auto=format)
.png?fit=crop&auto=format&w=3840&q=75)
Typical Payer Coverage Criteria for Multiple Sclerosis Therapies
Examining Challenges with Drug Switching and Step Therapy in MS Treatment
Incorporating a Subcutaneous Novel Therapy into Multiple Sclerosis Treatment
MS Treatment Guidelines: Expert Insights on Updates and Decision-Making
Dr Ari Green on Promising Remyelination Therapies and Patient Outcomes in MS
Dr Mitzi Joi Williams Discusses Clinical Trial Accessibility Challenges, Solutions
Dr Krystyn Van Vliet on Tackling Scalability, Cost When Using 3D Platforms for MS Drug Discovery
The Promise of Frexalimab in MS: Part 3
Dr Krystyn Van Vliet on Using Engineered 3D Platforms to Identify Potential MS Drug Candidates
The Promise of Frexalimab in MS: Part 2
Millennials With Multiple Sclerosis: Are They Different or Has Medicine Evolved?
Podcast: This Week in Managed Care—Challenges of Rural Healthcare Delivery and Other Health News
Podcast: This Week in Managed Care—Opioid Ruling and Settlement, and Other Health News
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
The Role of the Specialty Pharmacist in Optimizing Treatment for Amyotrophic Lateral Sclerosis: The Impact of Early Intervention, Patient-Centered Care, and Disease-Modifying Therapies in Slowing Disease Progression
Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances
New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
Exploring Transthyretin-Mediated Amyloidosis and Its Phenotypes: A Comprehensive Approach to Patient Treatment
The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation
More News
